Created in 1986, POLIDIS Laboratory is a human-sized company which has built its reputation in the field of medical devices. Its recognized expertise in the world of condoms also extends to pregnancy tests, ovulation tests, pain relief gels, food supplements as well as a wide range of anti-lice and nit products (shampoo, treatment cream, two-phase lotion and nit remover). Its status as a French manufacturer as well as the excellent reputation of its products make the POLIDIS Laboratory a privileged partner of the French Pharmacy. Innovation is the key to success. This is why we ask our teams for the …

11 similar entities Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

160 private practitioners bringing together numerous specialties practice there thanks to a high-level technical infrastructure. In addition, multidisciplinary medical teams provide, 24 hours a day, safe care for hospitalized or emergency patients. 500 healthcare professionals are present daily with patients. The establishment, organized into different centers of activity, offers a complete care pathway which includes diagnostic, therapeutic and rehabilitation care. Medical and interventional cardiology, Specialty medicine, Specialty surgery, Emergency medicine, Diagnosis, Perinatal care, and Post-care and rehabilitation

73 similar entities Type: SMB Activities: healthtech Technologies: Synthetic Biology

Facilitators of Life Sciences Research We facilitate Life Sciences Research every day, contributing to advance Science for a brighter future. Through our local offices located across Europe, we support Life Sciences and Biotechnology Researchers with a unique, holistic range of solutions to advance their projects faster:​ - We enable researchers to be at the forefront in their Research with access to cutting-edge biological solutions sourced from reputed global Life Sciences suppliers, carefully selected by our Scientific Team for their relevance and evaluated for their ethical and legal compliance. ​ - We accelerate their Research thanks to our Contract Research Services’ …

64 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Taking care of patients and the planet today for tomorrow! CHIESI is an Italian family biopharmaceutical group offering innovative therapeutic solutions to patients in 3 therapeutic areas: AIR (products and solutions for respiratory diseases from newborns to adults), RARE (treatments for rare and ultra-rare diseases), CARE (products and services in kidney and liver transplantation and prevention, in micronutrition) Bringing together more than 7,000 employees worldwide, CHIESI is present in France across the entire value added chain – R&D, production, distribution and provision to healthcare professionals and patients – with a turnover reaching more than €200 million in 2023. Certified B-Corp, …

Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

For 30 years, PiLeJe has distributed health solutions aimed at sustainably improving the quality and healthy life expectancy of patients with functional disorders, risk factors or chronic diseases. Complementary to medications, the health solutions developed by PiLeJe are prescribed by health professionals on the basis of individualized advice. To sustainably improve patient health, PiLeJe has expertise in four areas: health through microbiota, micronutrition, phytotherapy and medical nutrition. PiLeJe designs, manufactures, and distributes high-end, effective and natural health solutions. Key Figures: More than 700 employees worldwide Present in 35 countries including 6 subsidiaries (Spain, Benelux, Italy, Switzerland, Germany and Sweden) 350 …

Type: SMB Activities: healthtech biotech Technologies: Synthetic Biology

Green Common is the world’s first plant-based concept store to create a revolutionary food and lifestyle experience by introducing some of the most advanced global foodtech innovations. Its sales network has spread to over 10 countries and regions. Vegan, vegetarian, sustainability, food technology, food innovation, wholesale, distribution, marketing, branding, nutrition, green solution, corporate solutions, plant based, food 2.0, Beyond Burger, Marketing, Catering, Omnipork, and Alternative Protein

65 similar entities Type: Startup Activities: foodtech Technologies: Synthetic Biology

Protecting Today, Preserving Tomorrow Protecting Today, Preserving Tomorrow.

Type: SMB Activities: deeptech manufacturing Technologies: Synthetic Biology

Lab Quality Results Without The Lab! Revolutionizing diagnostics with fast, portable, and accurate DNA results. Based in Ottawa, Canada, Genomadix Inc. is a pioneer in real-time qPCR point of need technology, dedicated to the highest level of customer satisfaction, quality, and support, maintaining ISO 13485 medical device development and manufacturing standards certification. The Genomadix Cube is a real-time polymerase chain reaction (PCR) molecular diagnostic instrument capable of performing tests for precision medicine genotyping and environmental targets on a sample-to-result platform. The portable size, ease of use, and on-demand processing capability enables users to generate time-critical results in approximately one hour. …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Healthcare & Life Sciences communication agency Panacee is a communication agency specialized in health market. We deal with the main stakeholders of life sciences and medical area; #biotech, #medtech, #mhealth, #publichealth, #pharma Communication, Marketing, Santé, Scientifique, Sciences de la vie, Médical, Biotech, medtech, pharma, medical devices, Santé publique, identité visuelle, Digital, Print, réseaux sociaux, BtoB, professionnels de santé, chercheurs, patients, and strategie de communication

114 similar entities Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

Helping you achieve positive outcomes for your patients The world needs you at your best, so we create breakthrough solutions that help you save valuable time and restore patients' lives. Medical products and solutions, Dental and orthodontic supplies, and Health information solutions

177 similar entities Type: SMB Activities: healthtech Technologies: Synthetic Biology

Conception et réalisation de vos projets d'Etudes Cliniques, Registres, Programmes d'Accès précoces, Home Nursing 🚀✨ Euraxi (CRO) is a project management specialist in the health sector, assisting clients with their projects since 1986. Our organisation and service offer have been perfectly tailored to meet the precise needs of our clients. We can take on all or part of your operations thanks to our multidisciplinary team. This team is organised into specialised units and is guided by the risk management and quality procedures inherent to the requirements of your projects. - Clinical Operations - Data Management, eTools & Statistics - Medical …

39 similar entities Type: SMB Activities: healthtech Technologies: Synthetic Biology

Turning clinical endpoints into value-driven milestones. Your trusted development partner. Part of Comac Medical Group. 🤝With over 25 years of experience and more than 30 supervised clinical trials, our team is specialised in early clinical development, transforming clinical data into value-creating assets for your company. We support leading biotechs such as ImCheck Therapeutics, Hephaistos Pharma, and Brenus Pharma, as well as prestigious clinical sites, like Gustave Roussy. Our expertise in FIH and PoC studies enables us to generate critical data that enhance your assets’ value and support your fundraising efforts. ILife is now part of Comac Medical Group, bringing clients …

70 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Your asset in design validation and regulation of medical devices

Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

Continuing education serving health professionals since 1980 Since 1980, Afar has been serving the training of professionals in public and private health establishments, social and medico-social establishments, local authorities and businesses. Now recognized as one of the main training players in these sectors, Afar continues its commitment to professionals by offering in particular an offer of expertise in the fields of management, health and safety at work, mental health, disability and mediation. Meeting the objectives of national and regional health programs, our training actions and CPD programs welcome more than 5,600 trainees per year, from more than 500 clients spread …

Type: SMB Activities: edtech healthtech Technologies: Synthetic Biology

Through its subsidiaries, Mayoly is a family-owned, independent, French pharmaceutical and dermatological laboratory with an international footprint. For more than a century, it has successfully been growing its business with a focus on Gastroenterology and Dermocosmetics. Our French industrial heritage relates to our values ​​of Responsibility, Pragmatism and Caring. We strive passionately and tirelessly to provide patients and people with the best possible healthcare daily, and aim to establish ourselves as a leader in Consumer Healthcare over the coming decades Our know-how applies to several therapeutic areas, such as gastroenterology, rheumatology, ENT, general medicine and general public health. We are …

12 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Explore the Unseen BioAxial is now part of Telight. Please follow our news at Telight LinkedIn page https://linkedin.com/company/telight TELIGHT specializes in a field of instruments employing light optics, in particular, providing innovative types and solutions for light microscopy. Super Resolution Microscopy, Fluorescence Microscopy, Conical Diffraction Optical Components, Nanoscopy, Living Cell Imaging, Low phototoxicity, Standard Workflow, Multicolor Imaging, and Intuitive

21 similar entities Type: Startup Activities: nanotech deeptech Technologies: Synthetic Biology

Fytexia is a life science company that specialises in developing scientifically-supported active ingredients for dietary supplements. Fytexia’s mission is to reduce the risk factors associated with conditions affecting overall quality of life. We achieve this by offering innovative nutritional ingredients backed by scientific research and public health recommendations. Fytexia’s innovation team collaborates with a global network of scientific researchers to develop functional ingredients that undergo rigorous scientific scrutiny, from characterising the active compounds to clinically demonstrating their benefits. Fytexia's ingredients increase the value of the most advanced health products, contributing to the wellbeing of consumers, worldwide. Fytexia is part of …

Type: SMB Activities: healthtech deeptech foodtech Technologies: Synthetic Biology Bio sourced materials

Bionest Partners is a global consulting firm focused on Pharma, Biotech, Medical Device and Diagnostics that helps clients navigate complex product development issues in order to drive growth, create value and gain competitive advantage. We also offer our expertise and analytic skills to support investors with due diligence assignments in these markets. Bionest consultants are valued strategic partners who have helped more than 250 companies around the world build high-value product portfolios, optimize development approaches and prepare for commercial success. Our track record includes more than 500 successful projects consisting of innovative, creative and differentiated action plans grounded in in-depth …

63 similar entities Type: SMB Activities: healthtech biotech deeptech consulting Technologies: Synthetic Biology

Unisigma specializes in creating new varieties of cereals and protein peas.

Type: SMB Activities: it services Technologies: Synthetic Biology

Let the magic happen with our enzymes! Solyve (formerly Soufflet Biotechnologies) is a French producer and formulator of enzymes and biosolutions, based in Normandy since 1989. Our team of experts develops enzymatic solutions to help food companies meet challenges such as process optimization and improving the quality of food and beverages. Our mission and belief are to provide our partners—manufacturers, formulators, and distributors—with effective, sustainable, and non-GMO enzymatic alternatives. ENZYMES, BIOLOGICAL SOLUTIONS, BIOINNOVATION, WINEMAKING, BREWING, DISTILLING, BAKING, FRUIT AND VEGETABLE PROCESSING, PECTINASES, AMYLASES, PROTEASES, CELLULASE, HEMICELLULASE, PROTEIN HYDROLYSIS, TVP, AROMAS, SUSTAINABILTY, R&D, CIDER, OENOLOGY, BEER, JUICES, VEGETABLES, and YIELD

14 similar entities Type: SMB Activities: foodtech Technologies: Synthetic Biology

Catalyzing the development of transformative genetic-based therapeutics from concept to clinic. **The Gene Therapy Program at the University of Pennsylvania transitioned its activities to Gemma Biotherapeutics (GEMMABio) and Franklin Biolabs on October 1, 2024. ** Dedicated to discovery + translational research and led by Dr. James Wilson, the Gene Therapy Program (GTP) at the University of Pennsylvania focuses on the development of next-generation gene transfer vectors and their application in the treatment of a variety of acquired and inherited diseases. Dr. Wilson's commitment to patients with rare diseases stems from his days as a graduate student and medical student at …

13 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Best-in-class viral vector and nucleic acid development and manufacturing services Exothera is a contract research, development, and manufacturing organization (CDMO) dedicated to viral vector and nucleic acids production. As a technology-driven company, Exothera provides best-in-class bioprocessing expertise that capitalizes on the best and most innovative manufacturing technologies developed within the Univercells group. The company delivers accelerated discovery services as well as process development/optimization to rapidly reach GMP clinical and commercial production of viral vectors and nucleic acids. At Exothera and Univercells, Our mission is to make life-changing therapies available to all. As a Univercells company, Exothera capitalizes on novel manufacturing …

3 similar entities Type: Startup Activities: deeptech biotech manufacturing Technologies: Synthetic Biology

Please view our Community Guidelines, https://www.msd-animal-health.co.uk/social-media MSD Animal Health is the global animal health business unit of MSD. Through our commitment to the Science of Healthier Animals®, we offer veterinarians, farmers, pet owners and governments one of the widest ranges of veterinary pharmaceuticals, vaccines and health management solutions and services as well as an extensive suite of digitally connected identification, traceability and monitoring products. We are dedicated to preserving and improving the health, welfare and performance of animals and the people who care for them.

45 similar entities Type: Startup Activities: healthtech pettech Technologies: Synthetic Biology

Medincell is a pharmaceutical company at commercial stage. We develop a portfolio of long-acting injectables in various therapeutic areas. Our proprietary technology BEPO® aims to ensure patient compliance, improve the effectiveness and accessibility of treatments, and reduce their environmental footprint. We collaborate with tier-one pharmaceutical companies and foundations to improve Global Health through new therapeutic options. Our mission is to contribute to the improvement and protection of the health of populations across the world. The fair sharing of the value created with all our employees is the foundation of our business model. The sustainability of MedinCell is an essential condition …

62 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

InnovPulse is a medical devices company based out of France.

Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

SUDOSCAN - Impeto Medical Early detection and follow-up of autonomic neuropathy Impeto Medical SAS markets SUDOSCAN, a Class IIa Medical device regulated under the CE certification.

Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

ABL Europe is now part of the OXB Group More info at : oxfordbiomedica.com ABL Inc remains part of the Institut Mérieux Group More info at ablinc.com

Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Shaping the future of veterinary medicine through one-time therapies for major chronic pet health conditions. Scout’s mission is to harness the genetic revolution transforming human medicine to deliver the future of veterinary medicine. By combining world-leading talent in animal health and gene therapy technology, we have built a development platform for one-time therapies that address major areas of unmet medical need in pet medicine. We are a global company supported by leading life sciences investors and an R&D collaboration with the renowned Gene Therapy Program at the University of Pennsylvania. About Our Currently Enrolling Study for Cats Scout’s first therapy …

Type: Startup Activities: deeptech biotech pettech Technologies: Synthetic Biology

Discovery of innovative therapeutic antibodies for human and animal health MabGenesis is a biopharmaceutical startup that delivers first-in-class and best-in-class therapeutic monoclonal antibodies using technologies established by 30+ years of academic research. By using the innovative technology platform, high-quality phage display antibody libraries (MOURA Libraries) and efficient antibody isolation technology (IMPACT), MabGenesis makes it possible to isolate 100% species-specific monoclonal antibodies rapidly and efficiently. MabGenesis is a private company headquartered in Yokohama, Japan. For more information, visit https://mabgenesis.com/en Biotechnology, Antibody, Monoclonal antibody, VHH, membrane protein, Canine, Feline, GPCR, Autoimmune diseases, Cancer, Inflammatory diseases, Phage display antibodies, and Antibodydiscovery

55 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Their health is also ours. LAPROVET is a leading French veterinary laboratory in sub-Saharan Africa and with strong growth in South-East Asia and the Middle East. Building on our ambition to contribute to the long-term development of livestock sectors, the company has been able to grow and develop by putting its values at the forefront: - Quality with the manufacturing of veterinary medicines according to current European standards (GMP, BPL and BPD). - Education for local support and continuing training of breeders in the field thanks to an efficient network of national technical representatives The nature of human relationships within …

20 similar entities Type: SMB Activities: healthtech Technologies: Synthetic Biology

Delivering the iPSC platforms that ready the world for next-gen cell therapies Launched in April 2022, Cellistic specializes in process development and manufacture of cell therapies based on human induced pluripotent stem cell (iPSC) technology. The company’s focus and expertise in iPSC generation and differentiation protocol development makes it well-positioned to partner with innovative cell therapy developers to establish novel advanced therapies. With more than a decade of scientific and technical knowledge transfer from sister company Ncardia, Cellistic is uniquely experienced in designing and optimizing manufacturing procedures for iPSCs that deliver quality products at scale. For more information, visit www.cellistic.com.

44 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Dogs Saving Lives We train dogs to help the NHS and save lives Medical Detection Dogs works with the powerful scenting ability of dogs. We train them to detect the odour of diseases like cancers, Parkinson’s disease, malaria and potentially fatal bacterial infections, as well helping people with complex, life-threatening medical conditions stay safe and lead more normal, independent lives. Our Medical Alert Assistance Dogs save lives daily by alerting their human partners to an odour change which indicates an oncoming, potentially fatal medical event. Conditions W have trained dogs to alert to include Type 1 diabetes, PoTS, Addison’s disease …

Type: Startup Activities: deeptech healthtech biotech pettech Technologies: Synthetic Biology

You will monitor your health with your nutrition. IKI develops a home health lab for a personalized medical follow-up through simple and accurate urinary analyses. It is focused on the monitoring of lifestyle-related chronic diseases to provide better empowerment for Patients, remote monitoring tools for clinicians and cost-effective solutions for Payers. IKI a développé un laboratoire de santé à domicile, nommé URIKI, pour un suivi médical personnalisé grâce à des analyses urinaires simples, portables et précises. Il permet le suivi des maladies chroniques liées au mode de vie comme la maladie rénale chronique, les maladies cardio-vasculaires, les infections respiratoires et …

Type: Startup Activities: healthtech Technologies: Synthetic Biology

Epigenomics Switched On. Multiplexed Insight, Translational Impact Epigenica is a life sciences technology company at the forefront of innovations in epigenetic research. The company’s EpiFinder platform enables researchers to perform comprehensive epigenetic studies at unprecedented speed, scalability, and affordability. Epigenica is building a portfolio of products based on the EpiFinder platform to offer comprehensive high-throughput profiling at different depths of detail with an array of possible starting materials. The platform is powered by the company’s patented and proprietary high-throughput, multiplex, quantitative ChIP-seq technology (hmqChIP), the first commercial kit of its kind. With the advantages of the EpiFinder platform, Epigenica is …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Agile compliance for digital health. The world of health has been experiencing a technological revolution in recent years. Digitalization is today a major issue in the patient care journey, but also in the daily lives of healthcare professionals. At Theodo HealthTech, we support all health stakeholders in their e-health projects! Thanks to our experience in Lean and tech, combined with our knowledge of health, we design and develop digital medical devices that are integrated into the patient care pathway (digital therapies - DTx, virtualized clinical trials, digitalized care pathways). In the design of these products, we also ensure: adoption of …

79 similar entities Type: Startup Activities: healthtech Technologies: Synthetic Biology

Pigs. People. Planet. We’re proud to support pork producers. Our team works every day to do what’s right for pigs, people and the planet. The National Pork Board is a consumer-focused, producer-led organization that focuses on research, promotion and education to ensure the longevity of pork as a sustainable, nutritious protein. We lead the pork industry as a catalyst and connector to add value and build trust among those who produce, process, sell and consume pork. We strongly support our diverse workforce in many ways by fostering an inclusive and inviting environment. Please consider joining our team if this is …

Type: SMB Activities: deeptech Technologies: Synthetic Biology

Reshaping RecoveryTM Established in 2015 and based in France, SafeHeal is a clinical stage medical device manufacturer. Specializing in the development of anastomosis protection devices for colorectal surgery, SafeHeal’s premier device, Colovac, was invented to eliminate the need for diverting ostomies in patients undergoing colectomy. medical device

13 similar entities Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

Laboratoires Théa is a pharmaceutical industry specialized in ophthalmology. The group is the leader in several therapeutic classes as well as in the field of preservative-free eye drops. Laboratoires Théa is an innovative company dedicated to developing high-quality products that support ophthalmic care and eye health across more than 70 countries. Ophthalmology, Pharmaceuticals, Medical Devices, Eye care, Eye Health, and Preservative-free

14 similar entities Type: SMB Activities: healthtech biotech deeptech Technologies: Synthetic Biology

EDAP TMS is a recognized leader in robotic energy-based therapies. EDAP TMS develops, manufactures, promotes and distributes minimally invasive devices for various conditions using ultrasound technology. By combining the latest advancements in imaging, robotics, and the precise, non-invasive delivery of energy, EDAP TMS introduced the Focal One® in Europe and the United States as the leading focal therapy tool for the prostate, with the potential to expand to multiple indications beyond prostate cancer. EDAP TMS is listed on NASDAQ market in New York under ticker symbol “EDAP”. Medical Device, Prostate Cancer, HIFU, Urology, Therapeutic Ultrasound, Research & Development, and Endometriosis

Type: SMB Activities: healthtech manufacturing deeptech Technologies: Robotics Synthetic Biology

Ultimate predictability Since 1999, genOway aims at bridging the gap between preclinical findings and clinical success with advanced, genetically engineered preclinical models and solutions. From customized mice and rats to ready-to-use cell lines, our solutions provide increased predictability and accelerate therapeutic breakthroughs. We work with 17 of the world’s Top pharma companies—as well as leading biotech firms, CROs, and academic institutions. At the heart of genOway is a team of 150+ skilled professionals, from 17 nationalities, all committed to advancing preclinical research. What We Offer • A catalogue of validated, ready-to-use mice and cell lines—developed in partnership with biopharma leaders …

45 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

The box that takes care of you. French drug laboratory 🇫🇷 Biogaran, a French pharmaceutical laboratory founded in 1996, is the pioneer of generic medicines in France. For nearly 30 years, we have contributed to the sustainability of the health system and access to care for all. With more than 1,000 drug references and services designed to promote compliance, we play a key role in the health of the French people. Always on the move, Biogaran innovates and reinvents itself to meet the needs of each patient. Beyond generics, we develop biosimilar medicines, solutions for everyday ailments and wound care, …

48 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Phibro Animal Health is a leading global manufacturer of diversified veterinary products and mineral feed additives, with headquarters in Teaneck, New Jersey (USA) and numerous offices located around the world. We operate in over 30 countries, supporting the development and achievements of our clients. We are constantly conducting research and development, production and sales of innovative products medicinal products, in particular technologically advanced vaccines intended for poultry, which are the main specialization of our company. In 2012, Phibro entered the European market of nutritional products for dairy cattle. Today we offer two main products: OmniGen and Animate, but our goal …

5 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

HARNESSING NATURE FOR PEOPLE AND THE PLANET Octarine Bio is a Copenhagen-based company pioneering a new generation of sustainable, bio-based colourants produced via precision fermentation. We engineer nature inspired colours that deliver the performance, stability, and safety profile required for demanding industrial applications while decoupling colour from fossil based chemistry. Our PurePaletteTM portfolio offers bio-based colourants for use on textiles, plastics, packaging, and other materials. Designed for drop-in integration, PurePaletteTM targets price parity with conventional colourants in key use cases, enabling customers to adopt more sustainable solutions without compromising on cost, quality, or scalability. Synthetic Biology, Fermentation, Yeast metabolism, Plant …

14 similar entities Type: Startup Activities: cleantech deeptech greentech Technologies: Synthetic Biology

health technologies for everyone Interrupt Engineering is a medical device company known for its innovative products, including MoveMate, a wearable health technology designed to detect freezing of gait, a movement disorder commonly seen in Parkinson's patients. biyomedikal, elektronik, and medikal cihaz

88 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Rethink Medical S.L. is a start-up company dedicated to the development of new medical devices in the nursing field. Rethink Medical is a Spanish startup company focused on developing innovative medical devices, mainly in the nursing field, based on real life experiences regarding both patient needs and common hospital procedures. Our first patented product is a urinary catheter We are working on other continence-related projects as well, improving healthcare processes and patient comfort due to the aging of the population and the increased need for these products.

31 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

The first marketplace for second-hand medical devices for healthcare professionals. 🚀 Remma est la première marketplace de dispositifs médicaux d’occasion dédiée aux professionnels de santé. Notre plateforme permet aux médecins, cliniques et établissements de santé d’acheter et de revendre du matériel médical révisé, fiable et économique, tout en favorisant une approche d’économie circulaire. 🌍 En donnant une seconde vie aux équipements médicaux, nous contribuons à rendre la santé plus accessible, durable et responsable, tout en accompagnant les professionnels dans leurs besoins quotidiens en dispositifs médicaux. --- 🚀 Remma is the leading marketplace for refurbished medical devices, designed exclusively for healthcare …

Type: Startup Activities: healthtech Technologies: Synthetic Biology

Helping people with rare genetic diseases get answers. Probably Genetic helps undiagnosed rare disease patients find answers to their symptoms in a matter of weeks. There are over 400 million people worldwide that have a rare disease — more than cancer and HIV patients combined. Half of those patients are currently undiagnosed and half of them are children, and it takes 5-7 years on average for these patients to get a diagnosis. With our system, patients can get answers in a matter of weeks. Our online Symptom Checker identifies rare disease patients using state-of-the-art machine learning models, gets them tested …

Type: Startup Activities: insurtech deeptech Technologies: Synthetic Biology

Decoding tumor heterogeneity with real-time single-cell analysis .

Type: Startup Activities: deeptech Technologies: Synthetic Biology

Cellsway is a fresh deep-tech start-up founded in March 2020 in UK to convert the know-how and cutting-edge core technology that have been developed and cultivated at Mikro Biyosistemler Inc. into commercial products to set the gold standard for diagnosis and management of cancer. The flagship product of the company is a liquid biopsy platform which uses a simple blood sample for cancer diagnostics and cancer research. The patent-pending microfluidic technology enables isolation and enumeration of Circulating Tumor Cells (CTCs) from the blood samples of cancer patients.

60 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

We generate preclinical data that accelerates drug development. Modern research without blindspots, through a solution that unveils important insights in preclinical trials. Biotechnology , Drug development, Machine learning, Artificial Intelligence, Deep tech, Preclinical research, Animal welfare, and 3R

83 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

"Simplicity, the ultimate sophistication" (Leonardo da Vinci) X-Bolt brings simplicity and efficiency to trauma surgery, whilst improving quality of life for patients. surgery, orthopedics, medical devices, distribution, hip trauma, sales, marketing, and design

103 similar entities Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

Innovative biotech company developing next generation of cell culture systems designed to revolutionize biomanufacturing Cellevate develops and markets products based on a proprietary nanofiber-based platform - the Cellevat3dTM - with the potential to revolutionize upstream bioprocessing from R&D to commercial manufacturing. Our latest product line in development – Cellevat3dTM carriers – with a commercial launch planned for 2024, provides extracellular-like environments with exceptional surface areas for adherent cell cultures. Initial results show tremendous potential to increase yields, minimize risk and reduce costs in development and manufacturing. We offer a range of products based on our versatile and easily functionalized platform …

43 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

A clinical-stage immuno-oncology company developing proprietary oncolytic drugs as a novel therapy to fight cancer. Lytix Biopharma is a clinical-stage immunotherpy company developing a new class of oncolytic molecules designed to destroy tumors locally and elicit durable anti-tumor immunity. Our peptide-based oncolytic molecules, derived from host defense peptides, work through a dual mechanism: first, inducing rapid immunogenic tumor cell death that releases tumor antigens into the microenvironment; second, activating a lasting immune response that can prevent recurrence and improve responses to checkpoint inhibitors. Lytix is advancing ruxotemitide as a first-in-class oncolytic peptide for neoadjuvant melanoma, with broad potential across superficial …

15 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

Creating Innovative Pain Solutions Synerkine Pharma B.V. focuses on development of novel fusion proteins, called Synerkines, that combine the immunoregulatory activity of different cytokines. These fusion proteins have unique benefits over the individual cytokines and modulate a broad number of targets, including key elements in the pain pathway. This provides treatment options for chronic pain conditions with a clearly differentiated mechanism of action over current analgesic drugs and holds tremendous therapeutic and commercial potential. Synerkine Pharma B.V. was founded in 2018 as a spin-off of the University Medical Center Utrecht (UMCU), the Netherlands.

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Biopharmaceutical company performing discovery, rational design and initial clinical development of new MLT-based drugs. Laminar Pharma is a pioneering biopharmaceutical company that focuses on the discovery, rational design and development of a new generation of medicines that act through the innovative therapeutic strategy known as “Membrane-Lipid Therapy” (MLT). Laminar Pharma arose in 2006 as an academic spin-off to commercially develop new scientific know-how and applications generated by leading scientists at the University of the Balearic Islands (UIB) in Mallorca, Spain, headed by Prof. Pablo V. Escriba. Laminar Pharma aims to develop next-generation medicines, nutraceutical and cosmetic products based on the …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Pharmaceutical drug development company, focusing on late-stage development for treatment of serious rare diseases. Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development for commercialization for treatments of serious diseases with significant unmet medical needs in the orphan drug segment

51 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Monte Rosa Therapeutics is a clinical-stage biotechnology company developing highly selective molecular glue degrader (M Monte Rosa Therapeutics is a clinical-stage biotechnology company developing highly selective molecular glue degrader (MGD) medicines for patients living with serious diseases in the areas of oncology, autoimmune and inflammatory diseases, and more. Monta Rosa’s QuEENTM (Quantitative and Engineered Elimination of Neosubstrates) discovery engine combines AI-guided chemistry, diverse chemical libraries, structural biology and proteomics to identify degradable protein targets and rationally design MGDs with unprecedented selectivity. The QuEENTM discovery engine enables access to a wide-ranging and differentiated target space of well-validated biology across multiple therapeutic …

Type: Incubators & VCs Activities: biotech deeptech Technologies: Synthetic Biology

Development of covalent small molecules to transform the treatment of autoimmune and inflammatory disorders ARTICA Therapeutics and its seasoned team started operatons in 2020 and was supported by pre-Seed financing from BioGeneration Ventures. Artica is dedicated to developing novel small molecule medicines for inflammatory and autoimmune indicatons. Artca is at the forefront of covalent binding technology as well as in label-free cellular-based screening approaches. The unique combinaton of these capabilities allows rapid progression of the best drug candidates that have unprecedented and superior characteristics, creating novel and highly selective therapies for patients with unmet medical need.

21 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

AI-centric preclinical company discovering and developing novel biopharmaceuticals to treat cancer and rare diseases Onena Medicines is a biopharmaceutical company with a pipeline of first-in-class antibody medicines to treat recurrent and metastatic cancers and selected rare diseases. Onena’s drugs neutralize a new class of secreted ancient growth factors, conserved across species, called Dual SMAD Inhibiting Proteins (DSIPs), that program cancer cells to grow and resist chemotherapy. Blocking DSIPs, as demonstrated in-vivo by Onena, simultaneously reactivates physiological TGF-β and BMP signaling and elicits cellular reprogramming, resulting in cancer cells accepting environmental cell death signals from BMPs and Activins. Onena has developed …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology A.I.

Redefining Synthetic Lethality beyond HRD Tessellate BIO discovers and develops novel precision oncology medicines with the mission to turn cancer patients into cancer survivors. A private preclinical stage biotechnology company, Tessellate BIO is redefining Synthetic Lethality by developing drugs that target unexplored or difficult to drug pathways beyond HRD. Headquartered in the Netherlands and with research labs at the Stevenage Bioscience Catalyst, UK, Tessellate BIO is supported by top-tier life science investors BioGeneration Ventures (BGV) and Forbion. drug discovery, precision oncology, and biotechnology

45 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Developing a maternal vaccine for Group B Streptococcus MinervaX is pursuing the development of a maternal vaccine for the prevention of adverse pregnancy outcomes and life-threating infections caused by Group B streptococcus (GBS). The vaccine is based on adjuvanted proteins antigens covering close to 100% of clinical GBS isolates. Group B Streptococcal (GBS) is the leading cause of life-threatening infections in newborns. Colonization of pregnant women with GBS may lead to adverse pregnancy outcomes such as late abortions, stillbirths, and preterm delivery. Colonization may also lead to life-threatening infections in newborns for the first 3 months of life, causing pneumonia, …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Science Driven Development and Analytical Support - From Early Development to Commercialization. Coriolis Pharma is a globally operating and science driven contract research and development organization (CRDO). We support drug product development of biopharmaceuticals, including gene and cell therapies and vaccines, from early development to commercialization. Our focus lies on formulation development, lyophilization technologies and analytics (GMP and non-GMP) for a wide range of products. As a privately held and independent company with an interdisciplinary team of highly skilled scientists and an expert scientific advisory board, we provide cutting-edge services and tailor-made solutions for our clients. We offer a large …

97 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Building on innovative science to create treatments for patients in need ResoTher Pharma ApS is a biotechnology company focused on developing novel and effective peptide therapeutics for cardiovascular disease by targeting inflammation. Biotechnology, Drug Development, and Pharmaceutical Industry

743 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Protein interactomics by Proximity Networks® of single cells Pixelgen Technologies AB is on a mission to deliver biology at the highest resolution by understanding the molecular basis of cellular function with new tools and technologies that decipher the protein interactomics of single cells in unprecedented ways. The company’s patented Proximity Network Assay delivers nanoscale spatial analysis of immune cell proteins at ultra-high capacity and underpins the Pixelgen Proxiome Kit for precision medicine. A foundational technology, the Proximity Network Assay will power a portfolio of products for translational research to accelerate advances in immunology, hematology, and cell therapy. Pixelgen was founded …

4 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Better technology for better health LimmaTech Biologics AG is a Swiss-based clinical stage biopharmaceutical company. We are advancing our proprietary vaccine pipeline to halt the increasing threat of global infections due to emerging antibiotic resistance (AMR) and sexually transmitted diseases. In addition to our proprietary research, we also develop vaccines together with GSK. vaccines, research & development, biotechnology, and antimicrobial resistance

141 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

TRANSFORMING CARDIAC DRUG DISCOVERY HeartBeat.bio is a pioneering TechBio company leveraging a next-generation drug discovery platform to develop breakthrough medicines for heart failure patients. Heart failure is a rapidly growing global health crisis, affecting over 30 million people in major pharmaceutical markets, with limited treatment options. Despite its prevalence, innovation in this space has lagged—creating a massive opportunity for disruption. Our proprietary Cardioid Drug Discovery Platform integrates iPSC-derived cardiac organoids with AI-driven analytics and advanced automation. Unlike traditional drug discovery, which relies heavily on animal models with poor clinical translatability, our human-centric approach enables more predictive, efficient, and cost-effective drug …

10 similar entities Type: Startup Activities: deeptech Technologies: SaaS Synthetic Biology

Agomab is translating a deep expertise in growth factor biology to pioneer and develop novel treatments that aim to resolve fibrosis, repair tissue structure and restore organ function. Combining new scientific insights with robust drug development and a long-term corporate vision, we are building a broad clinical pipeline of differentiated programs with disease modifying potential in severe organ failure and fibrotic diseases.

145 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

AstronauTx is developing therapeutics to treat neurological disorders by improving sleep architecture. At AstronauTx our thesis is that changes in sleep architecture underpin disease and that sleep is a modifiable risk factor for chronic neurodegeneration. We have a unique portfolio of small-molecule therapeutics to restore dysregulated sleep physiology correcting sleep architecture to both improve symptoms and modify neurological disease progression.

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

French designer and manufacturer of medical devices since 1955 Allibert Medical, Corona Medical and Sotec Medical unite to form the HAcare group. By relying on the know-how of our brands, and the expertise of our teams, we can support you in the choice and installation of medical equipment (medical bed, ambulatory chair, stretcher, etc.), the management of the medication circuit (trolley, cupboard, etc.), home support and fitting out of common living areas (bedside table, dining table, bridge, etc.). lit médicalisé, mobilier modulaire, maintien à domicile, fauteuil ambulatoire, projet global, and accompagnement

106 similar entities Type: SMB Activities: healthtech manufacturing Technologies: Synthetic Biology

Shimadzu Chemistry & Diagnostics is one of the world leaders as a strategic supplier of stable isotope-labeled internal standards to Pharmaceutical, Food, Environment companies, as well as CROs (Contract Research Organizations), research laboratories and hospitals. The company also develops innovative reagent kits, using mass spectrometry technology (LC-MS and MALDI) as well as clinical software solutions designed to meet the needs of analysis laboratories. Shimadzu Chemistry & Diagnostics headquarter is based in Illkirch, France stable isotope, Stable isotope labelled (SIL) internal standards, Custom Synthesis, clinical solution, reagent kit, and clinical software/middleware

Type: SMB Activities: healthtech Technologies: Synthetic Biology

Posterem is a medicinal chemistry company that develops innovative molecules for therapeutic purposes against Cancer and Hearing Loss, as well as innovative active ingredients in the field of dermo-cosmetics. Posterm is a medicinal chemistry company which develops innovative therapeutic molecules against Cancer and Hearing Loss, as well as innovative active ingredients in the field of dermo-cosmetics.

6 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

We assist your efforts at work to reduce arduousness and the risks of MSDs We propose to reduce the risks of MSDs in industry, agriculture and logistics. Our manipulators and exoskeletons are suitable for manipulation applications in a large number of industrial sectors. Our cobots and exoskeletons aim to provide you with power and endurance to increase your efficiency and carry out your arduous manual tasks without the risk of MSD. Collaborative robots, Exoskeletons, Improvement of working conditions, ergonomics, anti TMS, risk prevention, cobots, job analysis, industry, logistics, public works, Viticulture, automotive, and market gardening

18 similar entities Type: SMB Activities: it services Technologies: Synthetic Biology

We design and offer a range of smart chemical libraries to ensure a high hit rate Prestwick Chemical is a French provider of smart libraries. For almost 20 years, the company, founded by Prof. Camille-Georges Wermuth, has provided medicinal chemistry services and screening libraries to accelerate small molecules drug discovery. Prestwick has a large portfolio of smart Libraries designed to ensure maximal chemical diversity, possibly to access new IP while remaining within reach of both low and high throughput screening processes. They are constantly updated and improved. Our clients have reported high quality hit generation rate. The Prestwick Chemical Library®, …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Intech is now EXALTA. Follow EXALTA Group for all news, insights, and company updates. Intech is now EXALTA. Follow us at https://www.linkedin.com/company/exalta-group/

31 similar entities Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

Our innovative technology from French research (CNRS Bordeaux) makes it possible to manufacture monodisperse polymer beads (CV<20%), very magnetic (iron oxide content >70%), calibrated from 100 to 500 nm (+/- 10 nm), offering a high specific surface area (5 to 25 m2/g). These magnetic beads are stable, sensitive and quickly separable under magnetic field. These particles are particularly well suited to be integrated into microfluidic devices. Their surface is, and can be, functionalized by the grafting of molecules of biological interest, in order to capture, isolate and separate, analyze or purify biological entities (molecules, oligonucleotides, cells, viruses) in a total …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

We power your science Sartorius Polyplus is a leading upstream solutions provider for advanced biological and cell and gene therapy production from research to commercial scale. An innovator in nucleic acid delivery, the legacy portfolio features process-centric transfection reagents, kits, and support services. Custom plasmid vector design was integrated into the offer in 2022 as a first measure to expanding the products and services portfolio to help customers (or the industry) optimize process economics while meeting strict scientific and regulatory standards. ​ ​ We wanted to share that we will not be actively posting or engaging on this LinkedIn account. …

27 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Your partner for preclinical research in Osteoarticular diseases, Inflammation, Skin diseases... Atlantic Bone Screen is a leading CRO (« Contract Research Organization ») specialized in high-quality preclinical evaluation services in the field of inflammation, osteoarticular diseases and skin diseases. Thanks to its high expertise, Atlantic Bone Screen evaluates drug candidates, biomaterials (either for orthopedic or dental applications) and ingredients/products for cosmetics and food industry. We provide high-quality services to support the characterization of drug candidates, nutraceuticals, biomaterials,... Located in Nantes, North-West of France and created in 2005, Atlantic Bone Screen puts at your disposal a unique preclinical platform with a …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Yes, you can. Invacare® is the benchmark supplier for Home Support Medical Devices. Our Products and Services are recognized for their quality and innovative nature. Listening to the needs of our Clients, we help give them back independence and autonomy on a daily basis. wheelchair, electric wheelchair, home support, medical bed, senior scooter, oxygen therapy, kuschall, alber, positioning, mobility, aquatec, and rea

18 similar entities Type: SMB Activities: transporttech consumer services deeptech healthtech Technologies: Synthetic Biology

APA Sport Health Expert efFORMip is an association which works to promote the integration of physical activity into the patient's care pathway. Under the acronym, Team to promote FITNESS in the interest of the patient, was created in 2005 under the leadership of Professor Danièle Rivière and Dr Frédéric Depiesse where several doctors and sports professionals in Midi-Pyrénées joined forces, convinced of the benefit of practicing physical activity in a therapeutic approach. Since 2018, it has been chaired by Dr Bernard Bros and managed by a board of directors whose members come from both the medical and physical activity sectors. …

6 similar entities Type: SMB Activities: healthtech Technologies: Synthetic Biology

CRO specialized in real-life data Kappa Santé was born from the desire to provide quality services in the fields of epidemiology, pharmacoepidemiology and public and digital health interventions. The company was founded at the end of 2002 and is based in Paris Kappa Santé is an independent CRO, member of ENCEPP (European Network of Centers for Pharmacoepidemiology and Pharmacovigilance), AFCRO (French Association of CROs), Oséo Excellence (community of entrepreneurs chosen by Oséo) and the Cap digital competitiveness cluster. We have now participated in more than 100 studies in numerous therapeutic areas Public health, Pharmaco-epidemiology, Medical devices, Intervention studies, Scientific communication, …

Type: SMB Activities: healthtech biotech deeptech Technologies: Synthetic Biology

Manufacturer of a medical device for estimating the stability of orthopedic implants during placement ImpacTell is a high-potential company specializing in the medical device market in the field of orthopedic implant placement. Using know-how acquired over ten years of research, our team is currently developing a medical device capable of recovering information on the biomechanical properties of the bone-implant interface. By assisting surgeons in their decision-making, our solutions are designed to improve the success rate of total hip prostheses and patient care. Medical device, orthopedic implants, bone-implant interface, hip prosthesis, acoustics, and biomechanics

31 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Since more than 10 years, AnyGenes® scientists develop and produce innovative high throughput screening products for signaling pathway analysis. These kits and reagents allow high throughput transcriptomic analysis of a large collection of signaling pathways in many species, biomarkers identification and validation, as well as validation of microarrays results. AnyGenes®, with its innovative & cost effective technologies, products and its proprietary molecular platform, helps scientists to accelerate their projects, publications, and biotech companies for drug development and biomarkers validation. Located in Paris, within Tenon Hospital in the 20th arrondissement, AnyGenes® constitutes a key player in the Biotechnology field. Supported by …

13 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Identify and quantify your Host cell proteins thanks to our HCP profiler solution! #TechnologicalCRO #HCP ANAQUANT provides pharmaceutical and biotech companies with high quality services in detection and quantification of proteins by mass spectrometry, in order to speed up their R&D. Thanks to its unique know-how in control and validation of protein quantification, ANAQUANT is a partner of choice for customized assay development of proteins. Our expertise in performing specific and sensitive assays – from one to several dozens of proteins in a small sample volume – significantly contributes to the success of discovery and validation of biomarkers. Our proprietary …

27 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

The glyco design company Kyron.bio is revolutionising the way we make our therapeutic drugs. Our novel engineering strategy allows us to precisely control the glycosylation pattern on the surface of a biologic in order to develop the next generation of medicines. This unique approach enables us to sculpt biologics based on the sugars that are attached to the surface, helping to make therapeutics safer and more effective. Our work at Kyron.Bio is opening up a new era of biologics engineering – one with the power to create positive health outcomes for patients whose needs are currently unserved. Bioproduction and Cell …

54 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Making it possible CLEAN BIOLOGICS is a CDMO for Viral vectors, Viral vaccines and oncolytic viruses and Biosafety testing for biological products. As well as a CMO for MCB & WCB production. GMP compliance

49 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

Affordable high-end neuroimaging We make and sell brain imaging systems showing neural activity called magnetoencephalographs (MEG). We democratize the use of MEG, using a space technology, to effectively detect brain defects and improve brain cares MEG, medical device, and functional imaging

Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Tackling bacterial infections, antimicrobial resistance, and their consequences in acute care settings. AUROBAC THERAPEUTICS is a biopharmaceutical company founded in 2022 by three highly renowned life sciences innovation companies, Boehringer Ingelheim, Evotec and bioMérieux, to become a global leader in the fight against bacterial infections, Antimicrobial Resistance (AMR) and their consequences in acute hospital settings. AUROBAC’s R&D strategy addresses these unmet medical needs with patient- and pathogen-targeted programs designed to tackle both the causes and consequences of potentially life-threatening bacterial infections and AMR, including hospital-acquired and ventilator-associated bacterial pneumonia (HABP and VABP) and sepsis.

15 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Therapeutic dialysis devices for metal extraction MexBrain develops medical devices capable of specifically, quickly and controlledly extracting metals. MexBrain has designed an ultrachelating platform: fluids capable of extracting metals associated with dialysis systems. These devices are specific to the targeted metals and have an adjustable extraction capacity. No medication or product circulates directly in the body, limiting side effects. Nanotechnologies, Dialysis, Metals, and Chelation

Type: Startup Activities: biotech deeptech healthtech nanotech Technologies: Synthetic Biology

Children with rare diseases deserve therapeutic answers ORPHELIA Pharma is a French pharmaceutical company based in Paris and Lyon that develops and markets medicines for the treatment of pediatric orphan diseases. ORPHELIA Pharma‘s mission is to provide patients with essential products in the fields of epilepsy and pediatric oncology, with formulations adapted to the pediatric population. With one drug approved in the European Union and one product in late-stage clinical development, ORPHELIA Pharma has recently established regional agreements in the European Union, the USA and China and conducts research projects through academic and industrial partnerships. Neurology, Pediatry, Orphan drug, and …

10 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Your Skin Designer LabSkin Creations is a biotechnology company specializing in advanced 3D skin and adipose tissue engineering. By combining innovative cell culture techniques as well as proprietary technologies based on scaffolding biomaterials and 3D bioprinting approaches, LabSkin designs and creates unique and versatile 3D reconstructed models for the performance evaluation of skin and personal care products and their ingredients. tests d'activité et d'efficacité, analyse d'image, Histologie, Immunohistochimie, Biologie cutanée, 3D, Reconstructed skin, and Adipose Tissue

53 similar entities Type: Startup Activities: deeptech industry 4.0 Technologies: Synthetic Biology

Molecular biology thought for your needs Biomnigene, a bioanalysis service company, helps prevent potential diseases and to authenticate, trace, secure, validate products and their effects through genetic analysis. Thanks to our expertise, we offer you integrated services for environmental, industrial (pharmaceutical, agro-food, cosmetic) or medical issues such as: - Analysis of the intestinal, skin, vaginal, pulmonary and soil microbiome (16S/ITS metagenomic, shotgun metagenomic, transcriptomic, WGS...). - Identification, quantification and authentication, monitoring of species in a pure sample and in a mixture (microorganisms, viruses, bacteria, meat, fish). - Genotyping - Antibody sequencing and safeguarding of hybridoma lines of special interest; - …

79 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Crossing the next frontier, to give you a fair chance to fight Exeliom Biosciences is a clinical-stage biotechnology company developing next-generation immunotherapies in immuno-oncology and immuno-inflammation. Our novel candidates harness microbiome-associated innate immune regulatory mechanisms. Inflammatory Bowel Diseases, Live Biotherapeutics, Microbiome, Immunotherapies, Immuno-oncology, and Immuno-inflammation

103 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Antineo aims to accompany customers in the preclinical development of novel anticancer agents. We provide services and strategic advice for preclinical development, optimal choice of in vitro and in vivo models as well as strategic input on potential indications to target in the therapeutic landscape. Développement préclinique, in vitro, ex vivo, in vivo, Preuve de concept, Expertise scientifique en pharmacologie, and Modèles à façon

147 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

INNERVATE. SCREEN. TRANSLATE. NETRI is an Techbio industrial start-up whose mission is to improve human health through the discriminating power of the nervous system. The company offers a Neuron-as-a-sensor suite (NaaS) to gain insights into the safety and efficacy of clinical or chemical compounds. NETRI focuses on pain quantification and pursues an exploratory pipeline in oncology-related adverse events, dermo-cosmetics, neurological disorders and neurotoxicity. Leveraging the natural capacity of neurons to encode biological interactions into electrical impulses, the NaaS suite features the world-first compartmentalized electrophysiology platform in standard 96-well plate format - NeuroFluidicsTM MEA - which acts as a data generation …

12 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Fabentech is a privately owned biopharmaceutical SME based in Lyon (France) and created in 2009, which develops immunotherapies to address situations of emergency. In an environment where the globalization of trade accelerates the spread of epidemics and where the geopolitical context increases the risk of bioterrorist attacks, nations should be prepared to address various situations of public health & medical emergency. However, there is generally no real therapeutic option to fight acute symptoms arising from these neglected indications. Based on its horse F(ab’)2 platform, a fully-derisked technology in-licensed from Sanofi Pasteur, Fab’entech aims to provide therapeutic solutions in the fields …

4 similar entities Type: Startup Activities: biotech deeptech healthtech manufacturing Technologies: Synthetic Biology

HesY, medical device for effective dental brushing in 10 seconds for healthcare and accommodation establishments 📢📢📢Our consumer product, Y-Brush, is available now: http://ow.ly/DMal30luqQK 🚀🚀🚀 FasTeesH is a Lyon startup developing a “toothbrush of the future” that cleans all teeth simultaneously, simply and effectively, in just 10 seconds. For what ? Few people like to brush their teeth. This daily task is therefore often “poorly” and/or “quickly” done. This can cause health problems, sometimes very serious. How ? Currently, we brush only 1 side of 1 tooth at a time. Our innovation allows you to brush 16 full teeth simultaneously using …

Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Biology x AI-powered drug development platform to transform precision oncology. Orakl Oncology leverages a unique collection of patient tumor avatars that combines biology and clinical data to fuel the therapeutic arsenal to fight cancer. With our platform we partner with oncology players to identify relevant targets and deliver new drugs, faster.

57 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology Data Analytics

The clear path to small molecule visualization & quantification Over the past decade, Immusmol specialized in the development of antibodies against low molecular weight compounds (<900 Daltons), eventually building a portfolio of unique primary antibodies and ELISA kits for research use. 50 + unique primary antibodies We develop monoclonal & polyclonal antibodies and staining procedures for the visualization of small molecules in cells & tissues. 80+ ELISAs cross-validated by LC-MS Our team develops highly sensitive ELISA kits to measure amino acids and their metabolites in biological samples. 600+ clients served worldwide We deliver our products worldwide through Fedex and developed …

17 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Which molecule will stand out INOVOTION is a biotech company which offers you a unique in vivo technology dedicated to anti-cancer treatment evaluations and early toxicity studies. Our Fast, Sensitive, Reliable and Affordable assay will save you time and money, to give you a clear competitive advantage. This breaking-thought technology, based on chick embryo, provides early analysis of your treatments before the classical preclinical stages. By eliminating low-value molecules early, INOVOTION accelerates your drug discovery process, increases your R&D productivity and reduces its costs. It’s rapid Go/No Go decision with multi-cancer screening capacities. This next generation of in vivo efficacy …

23 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Improving young children's health through digital therapies that combine medical efficacy with playful learning. LUDOCARE is a French digital health company on a mission: to prevent complications from pediatric asthma as early as possible. In France, asthma affects 1 in 10 children, causes over 42,000 hospitalizations each year, and remains the leading cause of school absenteeism. Yet, up to 75% of these hospitalizations could be avoided with better adherence to treatment and properly mastered inhalation techniques. This is the therapeutic purpose of JOE, our CE-marked Digital Medical Device, specifically designed to improve asthma control in children and prescribed by healthcare …

Type: Startup Activities: healthtech Technologies: Synthetic Biology